🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the safety of adjuvanted...
Status
Completed
Location
Center for Vaccine Development
Start Date
2016-08-01
Trial ID
NCT02810340
Treatments Being Tested
The purpose of this study is to detemine whether effect of Acetate-free sol...
Status
Completed
Location
Faculty of Medicine, Chulalongkorn University
Start Date
2012-10
Trial ID
NCT01778283
Treatments Being Tested
This is a phase 2 study that will consist of 3 visits during a 3 week perio...
Status
Completed
Location
Ora
Start Date
2009-01
Trial ID
NCT00833495
Objective: To assess the effect of autologous Platelet Rich Plasma (PRP) on...
Status
Completed
Location
Menoufia university hospital
Start Date
2018-04-01
Trial ID
NCT04669353
Treatments Being Tested
This study is a randomized, controlled, non-inferiority trial, that will be...
Status
Recruiting
Location
Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus
Start Date
2024-05-30
Trial ID
NCT06425978
Emergent reperfusion is the main goal for acute ischemic stroke therapy (AI...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2023-01-03
Trial ID
NCT05559398
Treatments Being Tested
This is a Phase 1, randomized, placebo-controlled, double-blinded study to ...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2024-06-26
Trial ID
NCT06444048
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of ocular ...
Status
Completed
Location
Site 501
Start Date
2012-05
Trial ID
NCT01602068
Treatments Being Tested
Numerous studies have shown that even when imaging does not reveal the pres...
Status
Recruiting
Location
Gustave Roussy
Start Date
2025-04-16
Trial ID
NCT06332274
Treatments Being Tested